Ledger.Open graph →
SEC Form D · Amendment · filed March 15, 2018

AiVita Biomedical, Inc

Offering
$5.5M
Sold
$5.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
IRVINE, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Gabriel S. Nistor · Irvine, CAExecHans S. Keirstead · Irvine, CAExec · DirectorAlexander B. Suh · Irvine, CADirectorSusan B. Bloomfield · Irvine, CADirectorEd B. Inal · Irvine, CAExecCamac Partners, LLC · New York, NYDirectorCamac Capital, LLC · New York, NYExecDavid Roblin · Abingdon, United KingdomExecan Arizona limited liability company Quyp Development Services LLC · Phoenix, AZExec · DirectorPeter T. Clark · London, United KingdomDirectorFabian Alt · Houston, TXExec · DirectorEckhard Alt, M.D., Ph.D · Houston, TXDirectorKlaus Keller · Houston, TXExecJohn L. Youngblood · New York, NYDirectorSandra L. Wijnberg · New York, NYExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗

AiVita Biomedical, Inc. — SEC Form D filing (2018) | Ledger